why do you think the eGFR data it is being withheld because it is at the very minimum good?

Also please could someone explain to me what the view on this board regarding the eGFR data. I have not kept track of what RVX management has said. I have seen some people reporting that management has said that all the most important CKD info has already been disclosed to the market i. the AHA presentation. But others seem to be saying there is still a big reveal... I am very confused here... surely if the eGFR data was so good then RVX would have released it in order to generate support for the shareprice when the finances are in such a parlous state. And also wouldn't CKD be the highest priority candidate in Breakthrough therapy designation given the complete lack of any treatment options currently? As I said, I am very confused. Please can someone enlighten me.

To invest in RVX is to suffer... I am still just about surviving 

Tundup